Preclinical antibiotic pipeline gets a pick-me-up

CARB-X, a public–private partnership aimed at bolstering the antibiotic pipeline, funded a diverse set of 17 early-stage drug development projects in its first year.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mullard, A. Preclinical antibiotic pipeline gets a pick-me-up. Nat Rev Drug Discov 16, 741–742 (2017).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing